Thalidomide

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

EDOCH Alternating With DHAP for New Diagnosed Younger MCL

The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction

Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma

Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy

Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease

Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

Long Term Beta Thalassemia Treatment: Findings From The Extension Period

Thalidomide Therapy for VEOIBD

A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia Patients